T. Rowe Price Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402M | Sell |
766,444
-1,408,582
| -65% | -$740M | 0.05% | 300 |
|
|
2025
Q1 | $1.38B | Buy |
2,175,026
+89,579
| +4% | +$56.8M | 0.17% | 118 |
|
|
2024
Q4 | $1.49B | Buy |
2,085,447
+810,144
| +64% | +$577M | 0.17% | 111 |
|
|
2024
Q3 | $1.34B | Buy |
1,275,303
+342,429
| +37% | +$360M | 0.15% | 130 |
|
|
2024
Q2 | $980M | Buy |
932,874
+30,261
| +3% | +$31.8M | 0.12% | 167 |
|
|
2024
Q1 | $869M | Buy |
902,613
+184,561
| +26% | +$178M | 0.11% | 180 |
|
|
2023
Q4 | $631M | Sell |
718,052
-1,499,613
| -68% | -$1.32B | 0.08% | 222 |
|
|
2023
Q3 | $1.83B | Sell |
2,217,665
-34,598
| -2% | -$28.5M | 0.27% | 74 |
|
|
2023
Q2 | $1.62B | Buy |
2,252,263
+74,031
| +3% | +$53.2M | 0.23% | 82 |
|
|
2023
Q1 | $1.79B | Buy |
2,178,232
+454,510
| +26% | +$373M | 0.27% | 76 |
|
|
2022
Q4 | $1.24B | Sell |
1,723,722
-26,839
| -2% | -$19.4M | 0.2% | 112 |
|
|
2022
Q3 | $1.21B | Buy |
1,750,561
+56,253
| +3% | +$38.8M | 0.2% | 103 |
|
|
2022
Q2 | $1B | Buy |
1,694,308
+813,967
| +92% | +$481M | 0.13% | 171 |
|
|
2022
Q1 | $615M | Sell |
880,341
-32,914
| -4% | -$23M | 0.06% | 293 |
|
|
2021
Q4 | $577M | Buy |
913,255
+103,415
| +13% | +$65.3M | 0.05% | 330 |
|
|
2021
Q3 | $490M | Sell |
809,840
-15,004
| -2% | -$9.08M | 0.05% | 350 |
|
|
2021
Q2 | $461M | Sell |
824,844
-37,899
| -4% | -$21.2M | 0.04% | 355 |
|
|
2021
Q1 | $408M | Sell |
862,743
-5,256
| -0.6% | -$2.49M | 0.04% | 374 |
|
|
2020
Q4 | $419M | Sell |
867,999
-45,993
| -5% | -$22.2M | 0.04% | 363 |
|
|
2020
Q3 | $512M | Sell |
913,992
-209,394
| -19% | -$117M | 0.06% | 297 |
|
|
2020
Q2 | $701M | Buy |
1,123,386
+116,053
| +12% | +$72.4M | 0.09% | 236 |
|
|
2020
Q1 | $492M | Buy |
1,007,333
+216,210
| +27% | +$106M | 0.08% | 260 |
|
|
2019
Q4 | $297M | Sell |
791,123
-75,877
| -9% | -$28.5M | 0.04% | 396 |
|
|
2019
Q3 | $241M | Buy |
867,000
+62,598
| +8% | +$17.4M | 0.03% | 413 |
|
|
2019
Q2 | $252M | Sell |
804,402
-952,724
| -54% | -$298M | 0.04% | 413 |
|
|
2019
Q1 | $722M | Buy |
1,757,126
+1,108,188
| +171% | +$455M | 0.11% | 202 |
|
|
2018
Q4 | $242M | Buy |
648,938
+60,983
| +10% | +$22.8M | 0.04% | 384 |
|
|
2018
Q3 | $238M | Sell |
587,955
-115,930
| -16% | -$46.8M | 0.03% | 442 |
|
|
2018
Q2 | $243M | Buy |
703,885
+14,130
| +2% | +$4.87M | 0.04% | 424 |
|
|
2018
Q1 | $238M | Sell |
689,755
-20,311
| -3% | -$6.99M | 0.04% | 415 |
|
|
2017
Q4 | $267M | Sell |
710,066
-61,664
| -8% | -$23.2M | 0.04% | 395 |
|
|
2017
Q3 | $345M | Sell |
771,730
-47,176
| -6% | -$21.1M | 0.06% | 335 |
|
|
2017
Q2 | $402M | Sell |
818,906
-292,969
| -26% | -$144M | 0.07% | 289 |
|
|
2017
Q1 | $431M | Buy |
1,111,875
+32,085
| +3% | +$12.4M | 0.08% | 264 |
|
|
2016
Q4 | $396M | Sell |
1,079,790
-117,674
| -10% | -$43.2M | 0.08% | 276 |
|
|
2016
Q3 | $481M | Sell |
1,197,464
-618,529
| -34% | -$249M | 0.1% | 240 |
|
|
2016
Q2 | $634M | Sell |
1,815,993
-2,203,784
| -55% | -$770M | 0.13% | 179 |
|
|
2016
Q1 | $1.45B | Sell |
4,019,777
-718,516
| -15% | -$259M | 0.31% | 76 |
|
|
2015
Q4 | $2.57B | Sell |
4,738,293
-59,862
| -1% | -$32.5M | 0.54% | 36 |
|
|
2015
Q3 | $2.23B | Buy |
4,798,155
+551,370
| +13% | +$256M | 0.5% | 39 |
|
|
2015
Q2 | $2.17B | Buy |
4,246,785
+370,284
| +10% | +$189M | 0.45% | 44 |
|
|
2015
Q1 | $1.75B | Sell |
3,876,501
-63,353
| -2% | -$28.6M | 0.36% | 62 |
|
|
2014
Q4 | $1.62B | Buy |
3,939,854
+680,192
| +21% | +$279M | 0.34% | 64 |
|
|
2014
Q3 | $1.18B | Buy |
3,259,662
+465,361
| +17% | +$168M | 0.26% | 96 |
|
|
2014
Q2 | $789M | Sell |
2,794,301
-1,308,589
| -32% | -$370M | 0.17% | 150 |
|
|
2014
Q1 | $1.23B | Sell |
4,102,890
-1,894,464
| -32% | -$569M | 0.28% | 91 |
|
|
2013
Q4 | $1.65B | Buy |
5,997,354
+468
| +0% | +$129K | 0.38% | 61 |
|
|
2013
Q3 | $1.88B | Sell |
5,996,886
-330,003
| -5% | -$103M | 0.47% | 44 |
|
|
2013
Q2 | $1.42B | Buy |
+6,326,889
| New | +$1.42B | 0.38% | 61 |
|